

The exact mechanism by which the risk factors produce PH has not been established. Given the fact that the absolute risk is generally low, factors of individual susceptibility are likely to play an important role. Risk factors and associated conditions for PAH are presented in the table below [1].
A “definite” association is defined as an epidemic, such as occurred with appetite suppressants in the 1960s, or large, multicenter epidemiologic studies demonstrating an association between a drug and PAH.
A “likely” association is defined as a single-center, case-control study demonstrating an association or a multiple-case series. “Possible” is defined as drugs with similar mechanisms of action as those in the “definite” or “likely” categories but which have not yet been studied (e.g., drugs used to treat attention-deficit disorder).
An “unlikely” association is defined as one in which a drug has been studied in epidemiologic studies and an association with PAH has not been demonstrated.
Table: Updated risk factors for and associated conditions of PAH
| Definite | Possible |
| Aminorex Fenfluramine Dexfenfluramine Toxic rapeseed oil | Cocaine Chemotherapeutic agents |
| Likely | Unlikely |
| Amphetamines L-tryptophan Methamphetamines | Oral contraceptives Estrogen Cigarette smoking |
PAH = pulmonary arterial hypertension; SSRI = selective serotonin reuptake inhibitor
Ref. Simmoneau G et al. JACC 2009; 54: Suppl S, S43-54
5th International Congress of the Swiss Society of Pulmonary Hypertension (SSPH)
28.-29. September 2012, Thun, Congress Hotel Seepark Thun
Informationen: www.imk.ch/sgph2012
SSPH Research Prize 2012
Deadline for submission: April 30, 2012
Further information
mehr